VIMOS – a Cosmology Machine for the VLT

Successful Test Observations With Powerful New Instrument at Paranal

One of the most fundamental tasks of modern astrophysics is the study of the evolution of the Universe. This is a daunting undertaking that requires extensive observations of large samples of objects in order to produce reasonably detailed maps of the distribution of galaxies in the Universe and to perform statistical analysis.

Much effort is now being put into mapping the relatively nearby space and thereby to learn how the Universe looks today. But to study its evolution, we must compare this with how it looked when it still was young. This is possible, because astronomers can “look back in time” by studying remote objects – the larger their distance, the longer the light we now observe has been underway to us, and the longer is thus the corresponding “look-back time”.

This may sound easy, but it is not. Very distant objects are very dim and can only be observed with large telescopes. Looking at one object at a time would make such a study extremely time-consuming and, in practical terms, impossible. To do it anyhow, we need the largest possible telescope with a highly specialised, exceedingly sensitive instrument that is able to observe a very large number of (faint) objects in the remote universe simultaneously.

The VLT VIsible Multi-Object Spectrograph (VIMOS) is such an instrument. It can obtain many hundreds of spectra of individual galaxies in the shortest possible time; in fact, in one special observing mode, up to 6400 spectra of the galaxies in a remote cluster during a single exposure, augmenting the data gathering power of the telescope by the same proportion. This marvellous science machine has just been installed at the 8.2-m MELIPAL telescope, the third unit of the Very Large Telescope (VLT) at the ESO Paranal Observatory. A main task will be to carry out 3-dimensional mapping of the distant Universe from which we can learn its large-scale structure.

“First light” was achieved on February 26, 2002, and a first series of test observations has successfully demonstrated the huge potential of this amazing facility. Much work on VIMOS is still ahead during the coming months in order to put into full operation and fine-tune the most efficient “galaxy cruncher” in the world.

VIMOS is the outcome of a fruitful collaboration between ESO and several research institutes in France and Italy, under the responsibility of the Laboratoire d`Astrophysique de Marseille (CNRS, France). The other partners in the “VIRMOS Consortium” are the Laboratoire d`Astrophysique de Toulouse, Observatoire Midi-Pyrenees, and Observatoire de Haute-Provence in France, and Istituto di Radioastronomia (Bologna), Istituto di Fisica Cosmica e Tecnologie Relative (Milano), Osservatorio Astronomico di Bologna, Osservatorio Astronomico di Brera (Milano) and Osservatorio Astronomico di Capodimonte (Naples) in Italy.

Media Contact

Richard West alphagalileo

All latest news from the category: Physics and Astronomy

This area deals with the fundamental laws and building blocks of nature and how they interact, the properties and the behavior of matter, and research into space and time and their structures.

innovations-report provides in-depth reports and articles on subjects such as astrophysics, laser technologies, nuclear, quantum, particle and solid-state physics, nanotechnologies, planetary research and findings (Mars, Venus) and developments related to the Hubble Telescope.

Back to home

Comments (0)

Write a comment

Newest articles

A world-first antibody-drug delivery system

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek…

Revealed: How SARS-CoV-2 evades our immune system

Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems. Researchers in Japan and the United States…

New approach developed to predict response of immunotherapies in lung cancer

New methodology at the University Hospital of Tübingen harnesses the function of platelets. At Tübingen University Hospital, a preclinical study led by Dr. Clemens Hinterleitner and Prof. Dr. Lars Zender,…

Partners & Sponsors